These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10027514)

  • 61. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H; Sjögren M; Agren H
    J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low prolactin response to fenfluramine in impulsive aggression.
    New AS; Trestman RF; Mitropoulou V; Goodman M; Koenigsberg HH; Silverman J; Siever LJ
    J Psychiatr Res; 2004; 38(3):223-30. PubMed ID: 15003426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.
    Padich RA; McCloskey TC; Kehne JH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):107-16. PubMed ID: 8935805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prolactin response to single and multiple doses of haloperidol in schizophrenic patients.
    Ravichandran GK; Lu RB; Shvartsburd A; Misra CH; Ho BT; Kahn M; Smith RC
    Psychiatry Res; 1984 Jan; 11(1):61-9. PubMed ID: 6584932
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.
    Monteleone P; Brambilla F; Bortolotti F; Ferraro C; Maj M
    Psychol Med; 1998 Jul; 28(4):975-83. PubMed ID: 9723152
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects.
    Coccaro EF; Kavoussi RJ; Oakes M; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Jul; 126(1):24-30. PubMed ID: 8853213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects.
    Cleare AJ; Bond AJ
    Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Haloperidol and droperidol treatment in schizophrenics. Clinical application of the "prolactin-model".
    Langer G; Pühringer W
    Acta Psychiatr Belg; 1980; 80(5):574-83. PubMed ID: 7234451
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR; Taylor CC; Kinon BJ; Breier A
    Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation.
    Mintzer J; Brawman-Mintzer O; Mirski DF; Unger R; Nietert P; Meeks A; Sampson R
    Biol Psychiatry; 1998 Nov; 44(9):918-21. PubMed ID: 9807649
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment.
    de Leon J; Diaz FJ; Josiassen RC; Simpson GM
    Eur Arch Psychiatry Clin Neurosci; 2004 Oct; 254(5):318-25. PubMed ID: 15365707
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls.
    Sher L; Oquendo MA; Li S; Ellis S; Brodsky BS; Malone KM; Cooper TB; Mann JJ
    Psychoneuroendocrinology; 2003 May; 28(4):559-73. PubMed ID: 12689612
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women.
    van Amelsvoort TA; Abel KM; Robertson DM; Daly E; Critchley H; Whitehead M; Murphy DG
    Psychoneuroendocrinology; 2001 Jul; 26(5):493-502. PubMed ID: 11337133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fenfluramine challenge in unipolar depression with and without anger attacks.
    Fava M; Vuolo RD; Wright EC; Nierenberg AA; Alpert JE; Rosenbaum JF
    Psychiatry Res; 2000 Apr; 94(1):9-18. PubMed ID: 10788673
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder.
    Chou JC; Douyon R; Czobor P; Volavka J; Cooper TB
    Psychiatry Res; 1998 Oct; 81(1):51-5. PubMed ID: 9829650
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
    Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
    Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prolactin response to fenfluramine in abstinent, alcohol-dependent patients.
    Porter RJ; Sellman D; Joyce PR; Davies J; Frampton C
    Addict Biol; 2008 Sep; 13(3-4):380-5. PubMed ID: 18279498
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of treatment with various doses of haloperidol on the pituitary-gonadal axis in male schizophrenic patients.
    Rinieris P; Hatzimanolis J; Markianos M; Stefanis C
    Neuropsychobiology; 1989; 22(3):146-9. PubMed ID: 2485861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.